Guna-cough

Dosage for Althaea Officinalis Leaf varies significantly based on the intended use and the preparation type.

For Allergenic Testing

In a clinical setting, an allergist will use a highly diluted liquid extract. For Skin Prick Testing (SPT), a single drop of the non-standardized extract (often 1:20 w/v) is applied to the skin, followed by a puncture. For Intradermal Testing, a much higher dilution (e.g., 0.02 mL of a 1:1000 w/v solution) may be injected into the dermis.

For Demulcent/Oral Use

• Infusion (Tea): 2 to 5 grams of dried leaf steeped in approximately 150 mL of water, taken 3 to 5 times daily. Cold maceration (soaking in cold water for 1-2 hours) is often preferred to maximize mucilage extraction while minimizing tannin extraction.
• Fluid Extract (1:1 in 25% ethanol): 2 to 5 mL taken three times daily.
• Syrup: 5 to 10 mL taken 3 to 4 times daily as needed for cough.

Althaea Officinalis Leaf is generally considered safe for children when used appropriately as a demulcent, but specific medical guidance is required.

• Children 6-12 years: One-half of the adult dose (e.g., 1-2 grams of leaf as tea, up to 3 times daily).
• Children 3-6 years: 0.5 to 1.5 grams of leaf as tea, up to 3 times daily.
• Children under 3 years: Use is generally not recommended unless specifically directed by a pediatrician due to the lack of robust safety data in this age group.

Renal Impairment

No specific dosage adjustments are provided in literature for renal impairment, as the primary components are not systemically absorbed. However, patients with end-stage renal disease should consult a physician to ensure no interference with fluid restriction protocols.

Hepatic Impairment

There are no known requirements for dosage adjustment in patients with hepatic impairment. The lack of systemic metabolism for the mucilage components suggests a high safety margin.

Elderly Patients

Elderly patients should be monitored for potential interactions with other medications, particularly regarding the timing of administration, as mucilage can slow the absorption of concurrent oral drugs.

When taking Althaea Officinalis Leaf orally, it is best to take it with a full glass of water. Because the mucilage can physically coat the stomach and potentially delay the absorption of other medications, it should be taken at least 1 hour before or 2 hours after any other oral medications. For the best demulcent effect in the throat, the liquid preparations (tea or syrup) should be sipped slowly to allow maximum contact time with the mucosal surfaces.

Storage: Store dried leaves or extracts in a cool, dry place away from direct sunlight. Keep liquid extracts refrigerated if specified by the manufacturer.

If you miss a dose of Althaea Officinalis Leaf, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up.

Overdose with Althaea Officinalis Leaf is rare and generally not life-threatening due to its low systemic absorption. Symptoms of excessive intake may include:

• Loose stools or diarrhea (due to the high fiber/polysaccharide content)
• Abdominal bloating
• Potential hypoglycemia in sensitive individuals

In the event of a massive ingestion or a severe allergic reaction (anaphylaxis) during diagnostic testing, seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When used as a demulcent at standard doses, Althaea Officinalis Leaf is exceptionally well-tolerated. However, some individuals may experience:

• Mild Gastrointestinal Changes: A slight increase in stool frequency or softening of the stool due to the high mucilage (soluble fiber) content.
• Fullness: A temporary feeling of abdominal fullness if taken in large quantities of liquid.

• Nausea: Occasionally reported when taken on an empty stomach in concentrated syrup forms.
• Bloating: Increased gas production as intestinal bacteria ferment the polysaccharides.
• Dizziness: Rarely reported and often associated with the underlying condition (e.g., a severe cough) rather than the herb itself.

• Hypoglycemia: There are theoretical concerns that Althaea may lower blood sugar levels by slowing glucose absorption in the gut. This is rare but may be more pronounced in patients already taking antidiabetic medications.
• Contact Dermatitis: Some individuals may develop a rash when handling the fresh or dried leaves.

While Althaea is generally safe, serious reactions are possible, particularly when used as an allergenic extract or in highly sensitive individuals.

> Warning: Stop taking Althaea Officinalis Leaf and call your doctor immediately if you experience any of these.

• Anaphylaxis: Symptoms include swelling of the face, lips, or tongue; difficulty breathing; wheezing; a rapid drop in blood pressure; and fainting. This is most likely to occur during clinical allergy testing.
• Severe Hives (Urticaria): Widespread, itchy red welts on the skin.
• Angioedema: Deep swelling beneath the skin, particularly around the eyes or throat, which can obstruct the airway.

There is limited data on the long-term use of Althaea Officinalis Leaf. Because it can interfere with the absorption of other nutrients and medications, chronic use without medical supervision could theoretically lead to sub-therapeutic levels of essential medications or minor nutritional deficiencies. However, no specific toxicities to the liver, kidneys, or bone marrow have been documented with prolonged use.

No FDA black box warnings currently exist for Althaea Officinalis Leaf. It is categorized as Generally Recognized as Safe (GRAS) for use in foods in the United States. However, as a non-standardized allergenic extract, it must only be administered by healthcare professionals equipped to treat anaphylaxis.

Report any unusual symptoms to your healthcare provider.

Althaea Officinalis Leaf is primarily used for its soothing properties, but it is not a substitute for medical treatment of underlying conditions such as chronic bronchitis, asthma, or gastrointestinal ulcers. Patients should ensure they have an accurate diagnosis before relying on botanical demulcents.

No FDA black box warnings for Althaea Officinalis Leaf.

• Allergic Reactions / Anaphylaxis Risk: Individuals with a known allergy to other plants in the Malvaceae family (such as okra, cotton, or hibiscus) should exercise extreme caution, as cross-reactivity is possible. During diagnostic skin testing, the risk of a systemic reaction, though low, requires the presence of emergency resuscitation equipment.
• Diabetes Management: Althaea Officinalis may lower blood glucose levels. Patients with diabetes or those prone to hypoglycemia should monitor their blood sugar closely while using this product, as it may necessitate an adjustment in their primary diabetes medications.
• Surgical Precaution: Due to its potential effects on blood sugar levels, it is recommended to discontinue the use of Althaea Officinalis Leaf at least two weeks before any scheduled surgical procedure.
• Gastrointestinal Obstruction: Patients with known narrowing of the esophagus or intestines should avoid large doses of mucilaginous herbs, as they could theoretically contribute to a blockage if not taken with sufficient fluid.

For most patients, routine laboratory monitoring is not required. However, certain populations may need:

• Blood Glucose Monitoring: For diabetic patients to ensure glycemic control is maintained.
• Therapeutic Drug Monitoring: For patients on narrow therapeutic index drugs (like digoxin or lithium), as Althaea may alter their absorption.

Althaea Officinalis Leaf does not typically cause sedation or cognitive impairment. It is generally considered safe to drive or operate machinery while using this substance. However, if you experience dizziness or an allergic reaction, refrain from these activities and consult your doctor.

There are no known direct interactions between Althaea Officinalis Leaf and alcohol. However, alcohol can irritate the mucous membranes that Althaea is intended to soothe, potentially reducing the efficacy of the treatment.

Althaea Officinalis Leaf can be stopped abruptly without the risk of withdrawal symptoms or physiological dependence. If you were using it to manage a chronic cough or gastric irritation, symptoms may return upon discontinuation.

> Important: Discuss all your medical conditions with your healthcare provider before starting Althaea Officinalis Leaf.

There are no documented 'absolute' drug contraindications where the combination is guaranteed to be fatal; however, Althaea Officinalis Leaf should not be used simultaneously with any medication where immediate absorption is critical for life-saving measures (e.g., certain emergency oral medications), as the mucilage may delay their onset of action.

• Antidiabetic Agents (e.g., Insulin, Metformin, Glyburide): Althaea may have additive hypoglycemic effects. Mechanism: Slowed carbohydrate absorption and potential intrinsic glucose-lowering properties. Consequence: Increased risk of low blood sugar. Management: Monitor blood glucose frequently and adjust medication doses under physician supervision.
• Narrow Therapeutic Index Drugs (e.g., Lithium, Digoxin, Warfarin): Mechanism: Physical adsorption or delayed gastric emptying caused by mucilage. Consequence: Reduced peak plasma concentrations (Cmax) or delayed time to peak concentration (Tmax), potentially leading to sub-therapeutic effects. Management: Administer Althaea at least 2 hours apart from these medications.

• Oral Contraceptives: While not definitively proven to cause failure, the delayed absorption could theoretically alter the hormonal peak required for efficacy. It is prudent to separate dosing.
• Diuretics: Althaea may have a mild diuretic effect, which could theoretically be additive with drugs like furosemide or hydrochlorothiazide.

• High-Fiber Diets: Combining Althaea with other high-fiber foods may further slow the absorption of medications and increase gastrointestinal side effects like bloating.
• Water Intake: Althaea must be taken with adequate water. Failure to do so can lead to the mucilage becoming overly viscous in the esophagus, potentially causing discomfort.

• Other Mucilaginous Herbs (Slippery Elm, Flaxseed, Psyllium): Using these together can significantly increase the 'barrier' effect in the gut, further impacting drug absorption.
• Hypoglycemic Herbs (Bitter Melon, Fenugreek, Chromium): May increase the risk of low blood sugar.

Althaea Officinalis Leaf is not known to interfere with standard blood chemistry or hematology panels. However, its use as an allergenic extract will obviously produce a positive result in skin prick tests for those sensitized to it.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Althaea Officinalis Leaf must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any patient with a documented severe allergy to Althaea Officinalis, its constituents (such as flavonoids or specific polysaccharides), or other members of the Malvaceae family. Reason: Risk of life-threatening anaphylaxis.
• Bowel Obstruction or Esophageal Narrowing: Patients with an active mechanical obstruction of the gastrointestinal tract. Reason: The mucilage can add bulk and viscosity, potentially worsening the obstruction.

Conditions requiring a careful risk-benefit analysis include:

• Poorly Controlled Diabetes: Due to the potential for unpredictable blood glucose fluctuations.
• Severe Gastroparesis: In patients where gastric emptying is already significantly delayed, the addition of mucilage may exacerbate symptoms of fullness and nausea.
• Acute Respiratory Distress: While Althaea is used for dry cough, it should not be used as a primary treatment for acute, severe respiratory distress where bronchodilators or steroids are indicated.

Patients who are allergic to the following may also react to Althaea Officinalis Leaf:

• Okra (Abelmoschus esculentus)
• Cottonseed (Gossypium spp.)
• Hibiscus
• Hollyhock (Alcea rosea)

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Althaea Officinalis Leaf.

FDA Pregnancy Category: Not formally assigned (typically treated as Category B or C).

There is a lack of high-quality, controlled clinical trial data regarding the use of Althaea Officinalis Leaf in pregnant women. Traditionally, it has been used without reported teratogenic effects; however, because it may affect blood glucose levels and nutrient absorption, it should only be used under the direct supervision of an obstetrician. Animal studies are insufficient to rule out all risks to fetal development.

It is unknown whether the constituents of Althaea Officinalis Leaf are excreted in human milk. Since the primary polysaccharides are not absorbed systemically by the mother, they are unlikely to reach the infant via breast milk. However, smaller phenolic compounds could potentially pass through. Use during breastfeeding should be limited to short durations and only after consulting a healthcare provider.

Althaea is frequently used in pediatric cough syrups in Europe and other regions. While generally considered safe for children over the age of 3, the dosage must be strictly controlled. It is not approved for the treatment of chronic lung conditions in children without a full medical evaluation. Parents should be aware of the risk of choking if dried leaf preparations are not properly strained or if capsules are given to young children.

The primary concern in the elderly is polypharmacy. Since many older adults take multiple medications for chronic conditions (e.g., blood thinners, blood pressure medication), the risk of Althaea interfering with the absorption of these drugs is high. Additionally, elderly patients with reduced thirst sensation must be reminded to take Althaea with sufficient fluids to avoid esophageal irritation.

There are no specific restrictions for patients with renal impairment, but these patients should be monitored for fluid balance, especially if they are on a fluid-restricted diet and are taking Althaea as an infusion.

No dosage adjustments are required for patients with hepatic impairment (Child-Pugh Class A, B, or C). The herb does not undergo significant hepatic metabolism that would lead to toxicity in the presence of liver disease.

> Important: Special populations require individualized medical assessment.

Althaea Officinalis Leaf acts primarily through its high concentration of mucilage polysaccharides (6-10%). These polymers consist of a backbone of D-galactose, L-rhamnose, D-glucuronic acid, and D-galacturonic acid.

1. 1Demulcent Action: Upon contact with water, these polysaccharides swell and form a bioadhesive gel. This gel adheres to the mucosal surfaces of the throat and stomach via hydrogen bonding and physical entanglement with endogenous mucin fibers. This creates a protective shield that prevents irritants (like stomach acid or dry air) from stimulating sensory nerve endings (nociceptors).
2. 2Anti-inflammatory Action: Some studies suggest that the flavonoids (such as kaempferol and quercetin) and phenolic acids in the leaf may inhibit pro-inflammatory cytokines, although this effect is secondary to the physical demulcent action.
3. 3Immunological Action: In allergenic extracts, the proteins act as antigens that cross-link IgE on mast cells, triggering the release of histamine.

• Onset of Effect: The demulcent effect on the throat is almost immediate upon ingestion of a liquid preparation. The effect on the gastric mucosa typically begins within 30 minutes.
• Duration of Action: The protective layer typically persists for 2 to 4 hours, depending on food and fluid intake which may wash the mucilage away.
• Tolerance: There is no evidence that patients develop pharmacological tolerance to the demulcent effects of Althaea.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (for polysaccharides) |

| Protein Binding | N/A (not systemically absorbed) |

| Half-life | N/A (local action) |

| Tmax | Immediate (local) |

| Metabolism | Colonic bacterial fermentation |

| Excretion | Fecal (major) |

• Molecular Formula: Complex mixture (Polysaccharides: [C6H10O5]n)
• Molecular Weight: High molecular weight polymers (>200,000 Da)
• Solubility: Mucilage is soluble in water (forming a gel); insoluble in alcohol.
• Structure: The leaf contains branched rhamnogalacturonans and linear glucans.

Althaea Officinalis Leaf is classified as a Non-Standardized Plant Allergenic Extract [EPC]. In a therapeutic context, it is categorized as a Botanical Demulcent and an Antitussive (Peripheral Type).